These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 18496028)

  • 21. All rights reserved: how the gene-patenting race is affecting science.
    Wuethrich B
    Sci News; 1993 Sep; 144(10):154-7. PubMed ID: 11659682
    [No Abstract]   [Full Text] [Related]  

  • 22. Impact of gene patents and licensing practices on access to genetic testing for hereditary hemochromatosis.
    Chandrasekharan S; Pitlick E; Heaney C; Cook-Deegan R
    Genet Med; 2010 Apr; 12(4 Suppl):S155-70. PubMed ID: 20393306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Bayh-Dole Act at 40: Accomplishments, Challenges, and Possible Reforms.
    Sarpatwari A; Kesselheim AS; Cook-Deegan R
    J Health Polit Policy Law; 2022 Dec; 47(6):879-895. PubMed ID: 35877952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Federal judge and government of the United States against gene patenting].
    Cassier M; Stoppa-Lyonnet D
    Med Sci (Paris); 2011; 27(6-7):662-6. PubMed ID: 21718652
    [No Abstract]   [Full Text] [Related]  

  • 25. Technology transfer at US universities: seeking public benefit from the results of basic research.
    Goodwin CD
    Technol Health Care; 1996 Sep; 4(3):323-30. PubMed ID: 8931243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patent and license pearls and pitfalls for taking an idea to the marketplace.
    Mukharji I
    J Investig Med; 2011 Jun; 59(5):758-61. PubMed ID: 21441827
    [TBL] [Abstract][Full Text] [Related]  

  • 27. University patenting and licensing practices in the United Kingdom during the first year of the COVID-19 pandemic.
    Keestra S; Rodgers F; Osborne R; Wimmer S
    Glob Public Health; 2022 May; 17(5):641-651. PubMed ID: 35298347
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Do March-In Rights Ensure Access to Medical Products Arising From Federally Funded Research? A Qualitative Study.
    Treasure CL; Avorn J; Kesselheim AS
    Milbank Q; 2015 Dec; 93(4):761-87. PubMed ID: 26626985
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of patenting on DNA diagnostic practice.
    Matthijs G; Hodgson S
    Clin Med (Lond); 2008 Feb; 8(1):58-60. PubMed ID: 18335671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 31. University-based science and biotechnology products: defining the boundaries of intellectual property.
    Kesselheim AS; Avorn J
    JAMA; 2005 Feb; 293(7):850-4. PubMed ID: 15713775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Policy forum: genetic technologies. Commercialization of genetic research and public policy.
    Knoppers BM; Hirtle M; Glass KC
    Science; 1999 Dec; 286(5448):2277-8. PubMed ID: 10636788
    [No Abstract]   [Full Text] [Related]  

  • 33. Genes and patent policy: rethinking intellectual property rights.
    Andrews LB
    Nat Rev Genet; 2002 Oct; 3(10):803-8. PubMed ID: 12360238
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Actor-network theory: a tool to support ethical analysis of commercial genetic testing.
    Williams-Jones B; Graham JE
    New Genet Soc; 2003 Dec; 22(3):271-96. PubMed ID: 15115034
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patenting genes and genetic research: good or bad for innovation?
    Arnold BE; Ogielska-Zei E
    Annu Rev Genomics Hum Genet; 2002; 3():415-32. PubMed ID: 12142363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patenting nanotechnology.
    Lemley MA
    Stanford Law Rev; 2005 Nov; 58(2):601-30. PubMed ID: 16395838
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survey confirms fears about licensing of genetic tests.
    Schissel A; Merz JF; Cho MK
    Nature; 1999 Nov; 402(6758):118. PubMed ID: 10646997
    [No Abstract]   [Full Text] [Related]  

  • 38. DNA as patentable subject matter and a narrow framework for addressing the perceived problems caused by gene patents.
    Schilling SH
    Duke Law J; 2011 Dec; 61(3):731-73. PubMed ID: 22165443
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patents in genomics and human genetics.
    Cook-Deegan R; Heaney C
    Annu Rev Genomics Hum Genet; 2010; 11():383-425. PubMed ID: 20590431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The fate and future of patents on human genes and genetic diagnostic methods.
    Huys I; Matthijs G; Van Overwalle G
    Nat Rev Genet; 2012 May; 13(6):441-8. PubMed ID: 22596320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.